The Zuckerberg San Francisco General Hospital and Trauma Center is a public hospital in San Francisco, California, under the purview of the city's Department of Public Health. It serves as the only Level I Trauma Center for the 1.5 million residents of San Francisco and northern San Mateo County.

During the past decade, San Francisco General Hospital conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 63 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 34 clinical trials were completed. i.e. 58.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Francisco General Hospital" #1 sponsor was "University of California, San Francisco" with 123 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 56 trials sponsored, "National Cancer Institute (NCI)" with 19 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Francisco General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 12 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 11 trials as a collaborator, "National Institutes of Health (NIH)" with 11 trials as a collaborator and "Medical University of South Carolina" with 10 trials as a collaborator. Other collaborators include 298 different institutions and companies that were collaborators in the rest 162 trials.

According to Clinical.Site data, the most researched conditions in "San Francisco General Hospital" are "HIV Infections" (95 trials), "HIV" (12 trials), "Pregnancy" (8 trials), "HIV Infection" (7 trials) and "Cardiovascular Disease" (6 trials). Many other conditions were trialed in "San Francisco General Hospital" in a lesser frequency.

Most popular intervention types in "San Francisco General Hospital" are "Drug" (175 trials), "Other" (58 trials), "Biological" (34 trials), "Behavioral" (32 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Zidovudine" (17 trials), "Laboratory Biomarker Analysis" (14 trials), "Didanosine" (9 trials) and "Indinavir sulfate" (9 trials). Other intervention names were less common.

The vast majority of trials in "San Francisco General Hospital" are 274 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 65 active trials in "San Francisco General Hospital". 4 are not yet recruiting, 37 are recruiting, 22 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 210 completed trials in San Francisco General Hospital, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in San Francisco General Hospital, 39 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 88 trials that are defined as “Not Applicable".

San Francisco General Hospital has several departments that took part in Clinical trials: "Children's Health Center at San Francisco General Hospital" - 2 trials